Five Trends in Contract Drug Manufacturing Organisations
Pharmaceutical Technology
SEPTEMBER 23, 2022
As pharma companies look to CDMOs for more support with product development, there is an increasing need for the CDMO to have in-house analytical development. This approach reduces cost, time, and errors by not having to rely on commercial size equipment that is scaled down to run pilot trials or bench top equipment that is scaled up.
147 
Let's personalize your content